P eroxisome proliferator-activated receptor-γ (PPARγ) is a ligand-activated transcription factor belonging to the nuclear receptor superfamily. Classically, PPARγ plays an important role in adipogenesis and metabolic processes but has recently emerged as a crucial element in cardiovascular diseases such as hypertension. Mutations of PPARγ lead to hypertension in humans and in experimental animal models. 1,2 Moreover, thiazolidinediones, high-affinity PPARγ agonists, which increase insulin sensitivity, have been shown to be helpful in lowering arterial pressure (AP) and improving vascular function. 3 We have previously shown that mice carrying a dominant-negative form of PPARγ specifically in smooth muscle (S-P467L mice) exhibit hypertension, severe aortic dysfunction, and hypertrophy of cerebral arterioles. 4 Vascular dysfunction occurs because of impaired expression of the PPARγ target gene regulator of G-protein signaling 5 (RGS5) leading to enhanced myogenic tone and angiotensin-II-mediated contraction in the mesenteric circulation, and impaired function of the cullin-3, cullin ring ligase pathway leading to increased RhoA and Rho kinase activity in the aorta. 5,6 Interestingly, these transgenic mice also exhibited robust tachycardia despite increased systemic AP, suggesting that interference with vascular smooth muscle PPARγ may impair the baroreflex. 4 The baroreflex is an important beat-to-beat regulator of AP and heart rate (HR). Baroreceptors, located in the adventitia of the aortic arch and carotid sinus, provide a highly sensitive system that detects changes in AP. These receptors send afferent signals to the central nervous system, and the efferent Abstract-S-P467L mice expressing dominant negative peroxisome proliferator-activated receptor-γ selectively in vascular smooth muscle exhibit impaired vasodilation, augmented vasoconstriction, hypertension, and tachycardia. We hypothesized that tachycardia in S-P467L mice is a result of baroreflex dysfunction. S-P467L mice displayed increased sympathetic traffic to the heart and decreased baroreflex gain and effectiveness. Carotid arteries exhibited inward remodeling but no changes in distensibility or stress/strain. Aortic depressor nerve activity in response to increased arterial pressure was blunted in S-P467L mice. However, the arterial pressure and heart rate responses to aortic depressor nerve stimulation were unaltered in S-P467L mice, suggesting that the central and efferent limbs of the baroreflex arc remain intact. There was no transgene expression in nodose ganglion and no change in expression of the acid-sensing ion channel-2 or -3 in nodose ganglion. There was a trend toward decreased expression of transient receptor potential vanilloid-1 receptor mRNA in nodose ganglion, but no difference in the immunochemical staining of transient receptor potential vanilloid-1 receptor in the termination area of the left aortic depressor nerve in S-P467L mice. Although there was no difference in the maximal calcium response to capsaicin in cultured nodose neurons from S-P467L mice, there was decreased desensitization of transient receptor potential vanilloid-1 receptor channels. In conclusion, S-P467L mice exhibit baroreflex dysfunction because of a defect in the afferent limb of the baroreflex arc caused by impaired vascular function, altered vascular structure, or compromised neurovascular coupling. innervation of blood vessels, heart, and kidneys make adjustments to maintain normal AP. 7 Clinical and experimental hypertension commonly involves cardiovascular autonomic impairment associated with high sympathetic activity and blunted baroreflex sensitivity with baroreceptor resetting.
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innervation of blood vessels, heart, and kidneys make adjustments to maintain normal AP. 7 Clinical and experimental hypertension commonly involves cardiovascular autonomic impairment associated with high sympathetic activity and blunted baroreflex sensitivity with baroreceptor resetting. 8 In this study, we hypothesize that the tachycardia observed in S-P467L mice is attributable to cardiovascular autonomic impairment and baroreflex dysfunction. Our data suggest that impairment in PPARγ function in smooth muscle can impair neurovascular coupling, which can attenuate afferent signaling to the central nervous system.
Materials and Methods
A detailed description of the transgenic mouse model, baseline cardiovascular measures, assessment of baroreflex sensitivity and efficacy, spectral analysis, mechanical properties of carotid artery, primary cultures of mouse nodose ganglia (NG), neurovascular coupling including calcium imaging as a measure of transient receptor potential vanilloid-1 receptor channels (Trpv1) functional properties, molecular measures, and data and statistical analysis are provided in the online-only Data Supplement. All studies were approved by the Institutional Animal Care and Use Committee in compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Results
We first measured AP and HR with radiotelemetry. S-P467L mice exhibited elevated AP (Figure 1A ) and were markedly tachycardic ( Figure 1B ). Intrinsic HR, measured after simultaneous sympathetic and parasympathetic blockade, was elevated in S-P467L mice (Figure 1B) . Consistent with increased sympathetic outflow to the heart, we observed a larger bradycardic response in S-P467L mice after administering the β-adrenergic antagonist propranolol (Figure 1C) . Similarly, the methyl-atropine induced tachycardic response was significantly smaller in S-P467L mice. Power spectral analysis revealed comparable relative low-frequency and high-frequency components between groups ( Figure S1A in the online-only Data Supplement). The low-frequency component of HR (Figure S1B ) and AP ( Figure  S1C ) predominated in S-P467L mice. S-P467L mice also exhibited increased systolic AP variability ( Figure S1D ). Applying the sequence method to examine spontaneous baroreflex fluctuations of AP revealed no changes in the number of sequences ( Figure S1E ), but S-P467L mice exhibited decreases in both baroreflex gain (Figure S1F ) and effectiveness ( Figure S1G ).
To assess whether the impairment in baroreflex function is because of alterations in vessel structure or function or both, the mechanical properties of carotid arteries were determined in the absence of vascular tone. The lumen diameter was significantly reduced in S-P467L carotid arteries across all pressures tested (Figure 2A ). However, there were no differences in vascular distensibility (Figure 2B) , and although the stressstrain curve was shifted to the right in S-P467L carotid arteries, the slope was not statistically different between the groups ( Figure 2C , nontransgenic: 2.61±0.03, S-P467L: 2.38±0.11; P>0.05), suggesting a similar stiffness.
Because baroreflex dysfunction in S-P467L mice could originate from either the afferent or the central (efferent) limb, we analyzed AP and HR in conjunction with aortic depressor nerve (ADN) activity at baseline and in response to various stimuli. We first examined the HR response to phenylephrine and sodium nitroprusside in nontransgenic and S-P467L mice under conscious conditions. S-P467L mice exhibited tachycardia at baseline (621±18 versus 527±26 bpm; P<0.01) and moderately elevated systolic AP (149.3±10.1 versus 139.5±8.4 mm Hg). S-P467L and nontransgenic mice exhibited equivalent pressor and depressor responses to phenylephrine and sodium nitroprusside, respectively (Figure 3A) . Although both S-P467L and nontransgenic mice exhibited similar tachycardic responses to sodium nitroprusside, the bradycardic response to phenylephrine was significantly blunted in S-P467L mice ( Figure 3B ).
We next measured ADN activity in nontransgenic and S-P467L mice under anesthesia. ADN activity occurred in bursts and was synchronous with the AP pulse in both nontransgenic and S-P467L mice ( Figure S2 ; Figure 4A and 4B). 9 There was no difference in baseline ADN activity between S-P467L (95±13 spikes/s) and nontransgenic (97±9 spikes/s) mice. The ADN response to sodium nitroprusside was comparable between nontransgenic and S-P467L mice ( Figure 4C and 4D). ADN activity rose abruptly in response to the pressor effects of phenylephrine in both groups, but the magnitude of the response was markedly blunted in S-P467L mice ( Figure 4C and 4D) .
The sigmoidal fitting ADN-AP curve is shown in Figure 5 . The baroreflex range, gain, and saturation pressure (MAPsat) were all significantly decreased in S-P467L mice, whereas the mean arterial pressure at 50% of ADN activity and threshold pressure were not different between groups (Table) . To examine the central integration of the afferent signal, we directly stimulated the ADN and monitored changes in AP and HR. Unlike the impaired response in S-P467L induced by acute Figure 1 . Arterial pressure and heart rate. Measurement of systolic arterial pressure (SAP), mean arterial pressure (MAP), diastolic arterial pressure (DAP), heart rate (HR), and intrinsic heart rate (iHR), using radiotelemetry. A, Average 1-hour recording of SAP, MAP, and DAP. B, Average HR over a 1-hour period calculated from the arterial pressure (AP) recordings and iHR calculated from the AP recordings after simultaneous blockage of sympathetic and vagal tone to the heart with propranolol and methyl-atropine, respectively. C, HR response to intraperitoneal injection of methyl-atropine (ATR) and propranolol (PROP). S-P467L (black) and nontransgenic (gray) mice. *P<0.05 vs nontransgenic (NT; n=8). increase in AP, the systolic AP and HR responses to ADN stimulation exhibited no differences between groups (Figure 6 ).
We next determined whether defects in the NG contribute to the impaired baroreflex sensitivity in S-P467L mice. Because PPARγ expression was recently identified in nodose neurons, we first assessed whether the smooth muscle promoter-driven transgene was expressed in NG in S-P467L mice. 10 No signal was detected in either the aorta or NG of nontransgenic mice. Although a signal (Ct value ≈28) was detected in NG from S-P467L mice, it was expressed ≈500-fold less than in the aorta ( Figure S3A ). There was no significant change in expression of the PPARγ target genes CD36 or aP2 in NG from P467L compared with nontransgenic (data not shown). Previous studies reported that the acid-sensing ion channel-2 (ASIC2) is expressed in aortic baroreceptor neurons and that Asic2-deficient mice exhibit baroreflex dysfunction. 11 However, there was no difference in the level of expression of either Asic2 ( Figure S3B ) or Asic3 ( Figure S3C ) mRNA in the NG of S-P467L mice. Trpv1 receptor channels have been implicated in baroreflex function, 12 but there was no detectable expression of Trpv1 mRNA in the aorta. Initial investigations suggested a decrease in mRNA encoding Trpv1 in NG from S-P467L mice, but ultimately, this trend was not significant ( Figure S3D ). Based on our early finding, we assessed whether there was histological evidence to support a defect in neural vascular coupling at the aorta arch. No obvious differences were observed between nontransgenic and S-P467L mice in the immunochemical staining pattern of Trpv1 in the termination area of the left ADN ( Figure 7A-7F ). In all specimens, both thick and thin fibers could be seen arising from the ADN in the aortic wall and bouton-like swellings and heavily branched terminal arrays similar to those reported elsewhere. 13 The mean numbers of grid intersections were 18.9±15.5 and 18.6±10.7 (nontransgenic versus S-P467L, t=0.237; P=1.0) for large fibers and 6.57±7.9 and 9.2±7.81 (nontransgenic versus S-P467L, t=0.851; P=0.4), indicating that there was no difference between the mean number of large fiber intersections and only a modest difference for fine fiber intersections.
Finally, we examined whether there was any change in the number of functional Trpv1 channels in the NG neurons by monitoring Trpv1-mediated increase in intracellular Ca 2+ ([Ca   2+ ] i ) responses (Figure 7G ] i rise in NG neurons of either genotype ( Figure 7H ), indicating no change in the levels of functional Trpv1 channel in these neurons. Interestingly, there was a significant decrease in the magnitude of Trpv1 channel desensitization in the NG neurons from S-P467L mice ( Figure 7I ).
Discussion
There is emerging evidence that the ligand-activated transcription factor PPARγ, best known for its regulation of adipogenesis, lipid metabolism, and insulin sensitivity, plays autocrine roles in tissues outside of its classical sites of action (eg, liver, skeletal muscle, and adipose tissue). Endothelial PPARγ-deficiency (through gene ablation) or PPARγ-interference (using a dominant-negative mutant) results in impaired nitric oxide-mediated vasodilatation and increased AP in response to a high-fat diet. [15] [16] [17] Smooth muscle PPARγ-deficiency blunts the protective effects of thiazolidinediones on atherosclerosis and augments angiotensin II-induced oxidative stress, inflammation, and vascular remodeling. 18, 19 Selective vascular smooth muscle interference with PPARγ causes a loss of nitric oxide responsiveness, an increase in vasoconstriction, and hypertension. 4 Despite mild hypertension, S-P467L mice exhibit robust tachycardia, suggesting impaired autonomic function. 4 S-P467L mice exhibited a blunted tachycardic response to vagal blockade and a markedly augmented bradycardic response to sympathetic blockade. The direct measurements of HR in response to pharmacological blockade suggest that there is increased sympathetic activity to the heart. This conclusion was further supported by spectral analysis, although it should be noted that the application and usefulness of spectral analysis remains controversial.
HR can be controlled by baroreceptors and chemoreceptors on free nerve endings in the aortic arch and carotid sinus, which transmit afferent signals to the brain in response to the local stretch of the vessel or changes in oxygen or pH. 20, 21 Theoretically, a lesion in any portion of the baroreflex arc can lead to baroreflex impairment. That the ADN response to an increase in AP was severely impaired in S-P467L mice suggests impairment in the afferent limb of the baroreflex arc. That the HR response to direct ADN stimulation was normal suggests that the central and efferent limbs of the baroreflex are functioning normally. This stands in contrast to other models of hypertension including the spontaneously hypertensive rat, deoxycorticosterone acetate-salt-treated rat, and obese Zucker rat, where the depressor response elicited by direct stimulation of ADN was attenuated suggesting a defect in the central component of the baroreflex arc. [22] [23] [24] Unlike the spontaneously hypertensive rat, which exhibits marked hypertension, the S-P467L mouse model displays only a small increase in arterial blood pressure but profound baroreflex dysfunction. Therefore, it is unlikely that the baroreflex dysfunction observed in S-P467L mice is because of increased AP.
The mechanical properties of the vascular wall and substances released by vascular cells have major influence on baroreceptor activity. For example, impaired release of prostacyclin, increased generation of reactive oxygen species, and platelet aggregation have been shown to reduce baroreceptor activity during hypertension and atherosclerosis. 25 Apolipoprotein E-deficient mice were reported to exhibit both hypertension and tachycardia, suggesting that hypercholesterolemia, atherosclerosis, or vascular structure and function or all of these may affect baroreflex regulation. 26 Vascular hypertrophy has been previously associated with the degree of baroreflex impairment. 27 We showed here that there was a decrease in the diameter (without a change in wall thickness) of the carotid artery, and our previous observations indicate that cerebral arterioles, but not mesenteric arteries, in S-P467L mice undergo hypertrophy, increased distensibility, and remodeling. 4 ,5 Thus, we must consider the possibility that the baroreceptor afferents in S-P467L mice may be unresponsive to increases in AP because of structural changes in the vessel. Alternatively, functional defects in the vessel may be playing an important role. Previous ex vivo studies revealed that the aorta from S-P467L mice exhibits markedly impaired responses to both endogenous and exogenous nitric oxide. 4, 6, 28 Interestingly, mesenteric vessels from S-P467L mice display large conductance Ca 2+ -activated K + channel dysfunction, 5 and polymorphisms in the KCNMB1 gene encoding the β1 subunit is associated with HR variability and baroreflex function in humans. 29 PPARγ is expressed in primary cultured microglia and cortical neurons where its protective effects may be a result of its antioxidant and anti-inflammatory actions. 30, 31 PPARγ is also expressed in the arcuate nucleus of the hypothalamus where it regulates the activity of a subset of neurons to control food intake. 32, 33 Nevertheless, it remains unclear whether PPARγ is expressed in the afferent nerves communicating baroreflex signals from the peripheral vasculature to the brain. Recently, PPARγ expression in the vagal nerve was reported to play a role in high-fat diet-induced thermogenesis. 10 We found no evidence for the expression of the transgene encoding dominant-negative PPARγ, nor a change in expression of 2 PPARγ target genes in peripheral NG nerves. Thus, PPARγ in nerves derived from the aortic arch and carotid sinus baroreceptors was unlikely to be affected. Asic2, Asic3, and Trpv1 have been mechanistically implicated to modulate the baroreflex. 11, 12 There was no change in Asic channel expression, but initial studies suggested that expression of Trpv1 might be decreased. This was attractive because Trpv1 channels are localized on the nerve fibers and terminals in the aortic arch and in NG neurons and because ablation or inhibition of Trpv1-containing neurons blunts the baroreflex. 12 Although there were no detectable 
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September 2014 differences in the number of Trpv1-expressing fibers at the termination of the left ADN, and no change in the maximal response to the Trpv1 ligand capsaicin, there was a significant decrease in the extent of channel desensitization in cultured NG neurons from S-P467L mice. This decrease in the magnitude of Trpv1 desensitization could lead to prolonged channel opening duration, which could promote action potential firing, that is, increased excitation of these neurons on Trpv1 activation. Physiologically, the Trpv1 channel could be activated by acidic pH (≤6.0) or noxious temperatures (≥43°C). 34 However, pathological conditions (eg, inflammation) could lead to the activation of Trpv1 at normal body temperature, as well as by relatively weak acidic pH (≈6.8-6.4). 14, 35 Under such circumstances, if the Trpv1 channel desensitization is decreased, it could lead to prolonged excitation of NG neurons. Of course, we recognize that this would stand in apparent contradiction to data showing that loss of Trpv1 causes baroreceptor dysfunction. 12 It is also possible that the decrease in channel desensitization constitutes a compensatory effect elicited by the decrease in Trpv1 expression, which could ultimately lead to a normalization of channel function.
Perspectives
The most important observations from this study are that mice with impaired PPARγ activity in vascular smooth muscle exhibit tachycardia mechanistically caused by any combination of the following: (1) increased cardiac sympathetic nervous system activity, (2) impaired baroreflex, and (3) a blunted ADN response to increased AP localized to the afferent limb of the baroreflex arc. Therefore, there may be some degree of baroreflex failure in S-P467L mice, which drives the increased HR.
Alteration in baroreflex function is a common problem in diabetes mellitus. Baroreflex sensitivity is decreased in patients with impaired glucose tolerance 36 and is blunted in patients with diabetes mellitus. 37 Likewise, animal models of diabetes mellitus display baroreflex alterations in a similar fashion to human diabetes mellitus. 38, 39 Depressed baroreflex sensitivity was reported to be predictive of other cardiovascular events in diabetes mellitus. 40 Of greatest relevance to the current study, pioglitazone, a high-affinity synthetic PPARγ agonist, increased baroreflex sensitivity in type II patients with diabetes mellitus. 41 Similarly, rosiglitazone, another member of the thiazolidinedione family of PPARγ agonists, improves baroreflex gain in rats with diet-induced obesity. 42 Given that diabetes mellitus is often associated with PPARγ impairment, these findings combined with our current study raise the possibility that diabetes mellitus-associated baroreflex alteration is a result of defective vascular PPARγ. Indeed our findings implicate vascular smooth muscle PPARγ as a critical determinant of neurovascular signaling. Thus, S-P467L mice may be a useful model to understand the decreased baroreflex sensitivity in diabetes mellitus.
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What Is New?
• Mice expressing dominant-negative proliferator-activated receptor-γ specifically in vascular smooth muscle (S-P467L) exhibit increased sympathetic activity to the heart and decreased effectiveness of the baroreflex.
• S-P467L mice exhibit decreased aortic depressor nerve activity in response to changes in arterial pressure, whereas arterial pressure and heart rate responses to direct aortic depressor nerve stimulation were similar in S-P467L and control mice
• These data suggest that the afferent limb of the baroreflex arc is impaired, whereas the central and efferent limbs of the baroreflex arc remain intact.
What Is Relevant?
• Proliferator-activated receptor-γ is a ligand-activated transcription factor classically playing an important role in adipogenesis and metabolic processes but more recently cardiovascular diseases such as hypertension.
• The baroreflex is an important beat-to-beat regulator of arterial pressure and heart rate, controlled by baroreceptors, located in the adventitia of the aortic arch and carotid sinus.
Summary
The most important observations from this study relate to the finding that mice with impaired proliferator-activated receptor-γ activity in vascular smooth muscle exhibit tachycardia mechanistically caused by any combination of (1) increased cardiac sympathetic nervous system activity, (2) impaired baroreflex regulation, and (3) a blunted aortic depressor nerve response to increased arterial pressure localized to the afferent limb of the baroreflex arc. Therefore, there may be some degree of baroreflex failure in S-P467L mice, which drives the increased heart rate. These findings implicate vascular smooth muscle proliferator-activated receptor-γ as a critical determinant of neurovascular signaling. 
Novelty and Significance

